Pine Labs Stock Price Today (NSE: PINELABS)
Fundamental Score
Pine Labs Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Pine Labs share price today is ₹245.67, up +0.00% on NSE/BSE as of 1 December 2025. Pine Labs (PINELABS) is a Large-cap company in the Financial Technology (Fintech) sector with a market capitalisation of ₹28.22K (Cr). The 52-week high for PINELABS share price is ₹N/A and the 52-week low is ₹N/A. The company has a Return on Equity (ROE) of -3.31% and a debt-to-equity ratio of 0.30.
Pine Labs Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Pine Labs Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Pine Labs Share Price: A Financial Stability Analysis
The Fintech landscape is currently experiencing a significant bifurcation. While digital payment adoption continues to surge, profitability remains a key challenge for many players. This analysis will evaluate the financial stability of Pine Labs, with a focus on key metrics influencing its long-term viability. The current Pine Labs share price sits at ₹245.67. This valuation must be assessed in the context of its financial performance, specifically its profitability and capital efficiency. This analysis forms part of an 80-parameter fundamental audit verified by Sweta Mishra.
One concerning factor is the company's Return on Capital Employed (ROCE) of -0.49%. ROCE measures how effectively a company generates profits from its capital investments. A negative ROCE, as seen with Pine Labs, indicates that the company is currently not generating sufficient returns to cover its cost of capital. This has a direct impact on the company's moat – its competitive advantage. A low or negative ROCE makes it difficult for Pine Labs to reinvest in growth, innovate, and maintain a strong position against competitors like
Infibeam Avenues Ltd. In contrast, assessing peer management quality, Infibeam Avenues Ltd has visibly taken strides in optimizing cost efficiencies from 2021-2024, further reinforcing their market position.The absence of a Price-to-Earnings (PE) ratio highlights that Pine Labs is currently not profitable, further emphasizing the importance of closely monitoring its future financial performance. While revenue growth might be present, sustainable profitability is crucial for long-term shareholder value creation. Companies like Seshaasai Tech. and Mosaic Company, while operating in potentially different segments, can offer comparative insights into achieving profitability and managing capital effectively.
It's important to note that this analysis is based on currently available data and observations. Financial performance can be affected by various factors, and further in-depth investigation is required to form a comprehensive assessment. No investment recommendations are made here, and readers should consult with a qualified financial advisor before making any investment decisions.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Pine Labs Fundamental Analysis & Valuation Benchmarking
Educational evaluation of PINELABS across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Consistent Growth Track Record (21.82% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Conservative Debt Levels (D/E: 0.30)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
6 factors identified
Below-Average Return on Equity (-3.31%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-0.49%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Weak Interest Coverage (-0.27x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-1422.55 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Low Promoter Commitment (0.00%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Pine Labs Financial Statements
Comprehensive financial data for Pine Labs including income statement, balance sheet and cash flow
About PINELABS (Pine Labs)
Pine Labs (PINELABS) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Financial Technology (Fintech) sector with... a current market capitalisation of ₹28.22K (Cr). Pine Labs has delivered a Return on Equity (ROE) of -3.31% and a ROCE of -0.49%. The debt-to-equity ratio stands at 0.30, reflecting the company's capital structure. Investors tracking PINELABS share price can monitor key metrics including P/E ratio, promoter holding of 0.00%, and quarterly earnings growth.
Company Details
PINELABS Share Price: Frequently Asked Questions
What is the current share price of Pine Labs (PINELABS)?
As of 01 Dec 2025, 04:21 pm IST, Pine Labs share price is ₹245.67. The PINELABS stock has a market capitalisation of ₹28.22K (Cr) on NSE/BSE.
Is PINELABS share price Overvalued or Undervalued?
PINELABS share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 36.33x. Based on this relative valuation, the Pine Labs stock appears to be Fairly Valued against its sector peers.
What is the 52-week high and low of PINELABS share price?
The 52-week high of PINELABS share price is ₹N/A and the 52-week low is ₹N/A. These values are updated daily from NSE/BSE price data.
What factors affect the Pine Labs share price?
Key factors influencing PINELABS share price include quarterly earnings growth (Sales Growth: N/A%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Pine Labs a good stock for long-term investment?
Pine Labs shows a 5-year Profit Growth of N/A% and an ROE of -3.31%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.30 before investing in PINELABS shares.
How does Pine Labs compare with its industry peers?
Pine Labs competes with major peers in the Financial Technology (Fintech). Investors should compare PINELABS share price P/E of 0.00x and ROE of -3.31% against the industry averages to determine competitive standing.
What is the P/E ratio of PINELABS and what does it mean?
PINELABS share price has a P/E ratio of N/Ax compared to the industry average of 36.33x. Investors pay ₹N/A for every ₹1 of annual earnings.
How is PINELABS performing according to Bull Run's analysis?
PINELABS has a Bull Run fundamental score of 12.5/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does PINELABS belong to?
PINELABS operates in the Financial Technology (Fintech) industry. This classification helps understand the competitive landscape and sector-specific trends affecting Pine Labs share price.
What is Return on Equity (ROE) and why is it important for PINELABS?
PINELABS has an ROE of -3.31%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Pine Labs generates profits from shareholders capital.
How is PINELABS debt-to-equity ratio and what does it indicate?
PINELABS has a debt-to-equity ratio of 0.30, which indicates conservative financing with low financial risk.
What is PINELABS dividend yield and is it a good dividend stock?
PINELABS offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Pine Labs shares.
How has PINELABS share price grown over the past 5 years?
PINELABS has achieved 5-year growth rates of: Sales Growth 21.82%, Profit Growth N/A%, and EPS Growth 10.60%.
What is the promoter holding in PINELABS and why does it matter?
Promoters hold 0.00% of PINELABS shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Pine Labs.
What is PINELABS market capitalisation category?
PINELABS has a market capitalisation of ₹28222 crores, placing it in the Large-cap category.
How volatile is PINELABS stock?
PINELABS has a beta of N/A. A beta > 1 suggests the Pine Labs stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is PINELABS operating profit margin trend?
PINELABS has a 5-year average Operating Profit Margin (OPM) of 8.17%, indicating the company's operational efficiency.
How is PINELABS quarterly performance?
Recent quarterly performance shows Pine Labs YoY Sales Growth of N/A% and YoY Profit Growth of N/A%.
What is the institutional holding pattern in PINELABS?
PINELABS has FII holding of 5.14% and DII holding of 9.91%. Significant institutional holding often suggests professional confidence in the Pine Labs stock.